Annual Long Term Debt
$6.61 B
+$479.37 M+7.81%
December 31, 2024
Summary
- As of February 26, 2025, RPRX annual long term debt is $6.61 billion, with the most recent change of +$479.37 million (+7.81%) on December 31, 2024.
- During the last 3 years, RPRX annual long term debt has fallen by -$481.42 million (-6.78%).
- RPRX annual long term debt is now -6.78% below its all-time high of $7.10 billion, reached on December 31, 2021.
Performance
RPRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$6.61 B
+$4.22 M+0.06%
December 31, 2024
Summary
- As of February 26, 2025, RPRX quarterly long term debt is $6.61 billion, with the most recent change of +$4.22 million (+0.06%) on December 31, 2024.
- Over the past year, RPRX quarterly long term debt has increased by +$479.37 million (+7.81%).
- RPRX quarterly long term debt is now -12.99% below its all-time high of $7.60 billion, reached on June 30, 2024.
Performance
RPRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
RPRX Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.8% | +7.8% |
| 3 y3 years | -6.8% | +7.8% |
| 5 y5 years | +11.1% | +7.8% |
RPRX Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.8% | +8.1% | -13.0% | +8.2% |
| 5 y | 5-year | -6.8% | +13.7% | -13.0% | +15.4% |
| alltime | all time | -6.8% | +13.7% | -13.0% | +15.4% |
Royalty Pharma Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $6.61 B(+7.8%) | $6.61 B(+0.1%) |
| Sep 2024 | - | $6.61 B(-13.0%) |
| Jun 2024 | - | $7.60 B(+23.8%) |
| Mar 2024 | - | $6.14 B(+0.1%) |
| Dec 2023 | $6.14 B(+0.3%) | $6.14 B(+0.1%) |
| Sep 2023 | - | $6.13 B(+0.1%) |
| Jun 2023 | - | $6.13 B(+0.1%) |
| Mar 2023 | - | $6.12 B(+0.1%) |
| Dec 2022 | $6.12 B | $6.12 B(+0.1%) |
| Sep 2022 | - | $6.11 B(-14.0%) |
| Jun 2022 | - | $7.11 B(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $7.10 B(+0.1%) |
| Dec 2021 | $7.10 B(+22.0%) | $7.10 B(+0.1%) |
| Sep 2021 | - | $7.09 B(+21.7%) |
| Jun 2021 | - | $5.83 B(+0.1%) |
| Mar 2021 | - | $5.82 B(+0.1%) |
| Dec 2020 | $5.82 B(-2.3%) | $5.82 B(+0.1%) |
| Sep 2020 | - | $5.81 B(+1.4%) |
| Jun 2020 | - | $5.73 B(-0.8%) |
| Mar 2020 | - | $5.77 B(-3.0%) |
| Dec 2019 | $5.96 B(-4.5%) | $5.96 B |
| Dec 2018 | $6.24 B | - |
FAQ
- What is Royalty Pharma annual long term debt?
- What is the all time high annual long term debt for Royalty Pharma?
- What is Royalty Pharma annual long term debt year-on-year change?
- What is Royalty Pharma quarterly long term debt?
- What is the all time high quarterly long term debt for Royalty Pharma?
- What is Royalty Pharma quarterly long term debt year-on-year change?
What is Royalty Pharma annual long term debt?
The current annual long term debt of RPRX is $6.61 B
What is the all time high annual long term debt for Royalty Pharma?
Royalty Pharma all-time high annual long term debt is $7.10 B
What is Royalty Pharma annual long term debt year-on-year change?
Over the past year, RPRX annual long term debt has changed by +$479.37 M (+7.81%)
What is Royalty Pharma quarterly long term debt?
The current quarterly long term debt of RPRX is $6.61 B
What is the all time high quarterly long term debt for Royalty Pharma?
Royalty Pharma all-time high quarterly long term debt is $7.60 B
What is Royalty Pharma quarterly long term debt year-on-year change?
Over the past year, RPRX quarterly long term debt has changed by +$479.37 M (+7.81%)